Approval · Notice of Compliance 36031 · 2025
TEVA-MYCOPHENOLATE: Notice of Compliance 36031
Issued September 19, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36031
- Date
- September 19, 2025
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Replacement of a drug product manufacturing site and/or manufacturer involving production. Change in the specification for the drug product. Update to package labels. Update to package insert. Change in the labelled storage conditions for drug product
- Canadian reference product
- CELLCEPT
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-MYCOPHENOLATE | Not yet assigned | — |
Medicinal ingredients
- MYCOPHENOLATE MOFETIL 500 MG per TAB